|
|
|
|
| TRADING CENTER |
53.64+0.68 / +1.28%
Abbott Laboratories (NYSE:ABT)
53.60-0.04 / -0.07
After hours quote
Prev. Close:
52.96
Open:
53.25
High:
53.74
Low:
52.84
Volume:
6,397,900
Volume Avg.:
7,875,200
52wk Range:
41.27 - 57.39
Market Cap (mil):
82,967.03
P/E Ratio:
14.94
Dividend Yield:
2.98%
| UPDATE: FDA Reviewing Safety Of Weight-Loss Drug Meridia - Dow Jones | |
| US FDA reviewing Abbott diet drug risks - Reuters | |
| FDA Reviewing Safety Of Weight-Loss Drug Meridia - Dow Jones | |
| Tech Unfazed by Dismal Dell ($) - at TheStreet.com | |
| 5-Star Stocks Worth a Look - MotleyFool.com | |
| 'Fast Money' Recap: Playing Defense - at TheStreet.com | |
| Abbott Hesitates To Promote Niaspan Study Due To FDA Rules - Dow Jones | |
| The Deal Names Abbott Top Dealmaker for Second Consecutive Year - PR Newswire | |
| Why You Can't Afford to Miss These Stocks - MotleyFool.com | |
| Drug Lowers Cholesterol; Stock Follows - MotleyFool.com | |
| UPDATE: Study Questions Utility Of Merck Cholesterol Drugs - Dow Jones | |
| Another Study Questions Utility Of Merck Cholesterol Drugs - Dow Jones | |
| FDA warns Abbott over diagnostics manufacturing - Reuters | |
| FDA Warns Abbott Over Manufacturing Violations At Plant - Dow Jones | |
| Abbott to Develop New Heart Failure Test on ARCHITECT(R) Immunochemistry Diagnostics ... - PR Newswire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 62.31 | -0.12 / -0.19% | 13.60 |
| PFE | Pfizer Inc | 18.36 | 0.25 / 1.38% | 15.43 |
| NVS | Novartis AG | 53.13 | -0.16 / -0.30% | 14.92 |
Short Interest Date:
Oct 30 2009
Short Interest Shares:
12,766,207
Short Interest Ratio:
1.6
Float:
1,541,874,359
Short Interest as a % of Float:
0.9%
Average Daily Volume:
9,503,600
Outstanding Shares:
1,546,738,426
Abbott Laboratories is an Illinois corporation, incorporated in 1900. The Company is mainly engaged in the discovery, development, manufacture, and sale of a line of health care products. The products included in the Pharmaceutical Products segment are: Humira(r), for the treatment of rheumatoid ... (more)
| 2008 Revenue: | $29.5 B | Headquarters: Abbott Park, IL |
| Employees: | 69,000 | CEO: Miles D. White |
| Net Income: | $4.9 B | Industry: Pharmaceuticals |
| Market Cap: | $83.0 B | Website: www.abbott.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| ABT | 53.64 | +0.68 / +1.28% | 52.96 | 53.74 | 52.84 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
